X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
32
PharmaCompass offers a list of Prednisolone Valerate Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prednisolone Valerate Acetate manufacturer or Prednisolone Valerate Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prednisolone Valerate Acetate manufacturer or Prednisolone Valerate Acetate supplier.
PharmaCompass also assists you with knowing the Prednisolone Valerate Acetate API Price utilized in the formulation of products. Prednisolone Valerate Acetate API Price is not always fixed or binding as the Prednisolone Valerate Acetate Price is obtained through a variety of data sources. The Prednisolone Valerate Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate, including repackagers and relabelers. The FDA regulates 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate supplier is an individual or a company that provides 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate active pharmaceutical ingredient (API) or 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate finished formulations upon request. The 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate suppliers may include 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate API manufacturers, exporters, distributors and traders.
click here to find a list of 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate Drug Master File in Japan (11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate JDMF) empowers 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate JDMF during the approval evaluation for pharmaceutical products. At the time of 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate Drug Master File in Korea (11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate. The MFDS reviews the 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate KDMF as part of the drug registration process and uses the information provided in the 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate KDMF to evaluate the safety and efficacy of the drug.
After submitting a 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate suppliers with KDMF on PharmaCompass.
11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate GMP manufacturer or 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate GMP API supplier for your needs.
A 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate CoA (Certificate of Analysis) is a formal document that attests to 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate's compliance with 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate specifications and serves as a tool for batch-level quality control.
11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate CoA mostly includes findings from lab analyses of a specific batch. For each 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate may be tested according to a variety of international standards, such as European Pharmacopoeia (11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate EP), 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate 17-valerate USP).
Market Place
